As a long-standing analytical chemist in pharmaceutical research with a focus on vibrational spectroscopy,

I recognized the potential impact VCD could have on many aspects of big pharma. With the ChiralIR I have successfully assigned the configurations of more than 600 exploratory drug molecules, providing an international service to research facilities in Europe and the United States. I consider this instrument to be world-class and a bargain for the price given its state-of-the art technology and incredible level of reliability.